BlockBeats News, April 1st, Decentralized protocol Bio Protocol, focusing on early-stage biotech, announced its first major protocol upgrade on Solana and Base — Bio V1. V1 introduces several features aimed at simplifying and optimizing early-stage biotech funding and development, and introducing novel incentive mechanisms, including:
· A community-governed Launchpad for early-stage funding;
· A liquidity and incentive engine supporting immediate post-funding liquidity and rewards tied to scientific milestones;
· BioAgents, AI-driven agents capable of automating research tasks such as R&D data analysis and experimental design.
BIO token holders can determine which biotech projects get launched and their development direction. In return, they are able to access early allocations of successful projects on the network. In the screening process, BIO token holders decide which new BioDAOs can receive funding support in the Bio V1 Launchpad. By contributing BIO, participants receive discounted BioDAO tokens.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。